Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...

Alterations in Muscle Tone ll

Alterations in Muscle Tone ll

Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Behavioral signature of trihexyphenidyl in the <i>TOR1A</i> (DYT1) knockin mouse model of dystonia.

Dystonia (Lausanne, Switzerland)·2026

Same author

Changes in Purine Metabolism During Differentiation of Dopamine Neurons from Human Induced Pluripotent Stem Cells.

Cellular and molecular neurobiology·2026

Same author

Modeling rare genetic disease with gene-edited induced pluripotent stem cells: relevance of the starting stock line.

Stem cells translational medicine·2025

Same author

Modeling rare genetic disease with patient-derived induced pluripotent stem cells: reassessment of the minimum numbers of lines needed.

Stem cells translational medicine·2025

Same author

Behavioral Signature of Trihexyphenidyl in The <i>Tor1a</i> (DYT1) Knockin Mouse Model of Dystonia.

bioRxiv : the preprint server for biology·2025

Same author

Striatal cell-type-specific molecular signatures reveal potential therapeutic targets in a model of dystonia.

Neurobiology of disease·2025

Same journal

Comment on: "Bilateral Deep Brain Stimulation of the Subthalamic Nucleus or Globus Pallidus Internus Improves Gait Impairment in Parkinson's Disease".

Movement disorders : official journal of the Movement Disorder Society·2026

Same journal

A Phase 1 Study of Convection-Enhanced Delivery of Intraputaminal AAV2-GDNF in Advanced Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·2026

Same journal

Reply to Comment on: "Bilateral Deep Brain Stimulation of the Subthalamic Nucleus or Globus Pallidus Internus Improves Gait Impairment in Parkinson's Disease".

Movement disorders : official journal of the Movement Disorder Society·2026

Same journal

Gene Therapy for Amino Acid Decarboxylase Deficiency: Clinical and Imaging Outcomes in a French Cohort.

Movement disorders : official journal of the Movement Disorder Society·2026

Same journal

Alzheimer's Disease Cerebrospinal Fluid Biomarkers Predict Survival in Progressive Supranuclear Palsy.

Movement disorders : official journal of the Movement Disorder Society·2026

Same journal

Hyperhomocysteinemia and Vitamin B Deficiency as Potential Aggravating Factors in Huntington's Disease: A Prospective Monocentric Study.

Movement disorders : official journal of the Movement Disorder Society·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 9, 2026

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia

Published on: September 12, 2020

Animal models for dystonia.

Bethany K Wilson¹, Ellen J Hess

¹Department of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322, USA.

Movement Disorders : Official Journal of the Movement Disorder Society

|July 30, 2013

Summary

This summary is machine-generated.

Animal models reveal basal ganglia and cerebellum dysfunction in dystonia, highlighting abnormal neurotransmitter signaling. This research provides a foundation for developing new therapeutic interventions for dystonia.

Keywords:

basal ganglia cerebellum mouse model primate model

More Related Videos

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

Low-cost Protocol of Footprint Analysis and Hanging Box Test for Mice Applied the Chronic Restraint Stress

Low-cost Protocol of Footprint Analysis and Hanging Box Test for Mice Applied the Chronic Restraint Stress

Published on: January 23, 2019

Related Experiment Videos

Last Updated: May 9, 2026

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia

Published on: September 12, 2020

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

Low-cost Protocol of Footprint Analysis and Hanging Box Test for Mice Applied the Chronic Restraint Stress

Low-cost Protocol of Footprint Analysis and Hanging Box Test for Mice Applied the Chronic Restraint Stress

Published on: January 23, 2019

Area of Science:

Neuroscience
Animal Models
Movement Disorders

Background:

Symptomatic animal models mimic human disorders, aiding the study of underlying anatomical and physiological processes.
These models are crucial for demonstrating causality in conditions where human studies are infeasible.

Purpose of the Study:

To investigate the neurobiological underpinnings of dystonia using symptomatic animal models.
To identify key brain regions and neurotransmitter systems involved in dystonia.

Main Methods:

Utilized rodent and primate models exhibiting dystonia-like symptoms.
Examined neurochemical alterations in the basal ganglia and cerebellum.

Main Results:

Identified abnormalities in striatal GABAergic (gamma-aminobutyric acid) and dopaminergic transmission within the basal ganglia.
Established the cerebellum's role, noting aberrant glutamate signaling and Purkinje cell activity.
Suggested that the basal ganglia and cerebellum form a dysfunctional integrated network in dystonia.

Conclusions:

Animal models provide critical insights into dystonia pathophysiology.
Findings point to a network dysfunction involving the basal ganglia and cerebellum.
This knowledge can guide the development of novel therapeutic strategies for dystonia.